MedTrace Logo

Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of AG1321001 in Chronic Cougher

NCT00380315 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 396

Last updated 2009-07-02

No results posted yet for this study

Summary

This study is for therapeutic confirmation of AG1321001 to evaluate the safety and efficacy as an anti-tussive agent in cough patients.

Conditions

Interventions

DRUG

AG1321001(drug)

Sponsors & Collaborators

  • Ahn-Gook Pharmaceuticals Co.,Ltd

    lead INDUSTRY

Principal Investigators

  • Young-hwan Kim, MD, PhD · Seoul National University Hospital, Seoul, 110-744, Korea, Republic of

  • Choon-Taek Lee, MD, PhD · Seoul National University Bundang Hospital, Sungnam, Korea, Republic of

  • Hee-Soon Chung, MD, PhD · Seoul National University Boramae Hospital, Seoul, 156-707, Korea, Republic of

  • Ki-suk Jung, MD, PhD · Hallym University Sacred Heart Hospital, Anyang, Kyunggi, 430-070, Korea, Republic of

  • Joon Chang, MD, PhD · Severance Hospital, Seoul, 120-752, Korea, Republic of

  • Chul-min Ahn, MD, PhD · Yongdong Sevenrance Hospital, Seoul, 135-720, Korea, Republic of

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Completion
2007-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00380315 on ClinicalTrials.gov